Medicenna Therapeutics Inc. announced that it has appointed Mr. Albert Beraldo, Mr. Andrew Strong and Dr. Chandra Panchal, as non-executive independent directors. Mr. Albert G. Beraldo, CPA, CA, has over 30 years' experience in varying roles within the pharmaceutical/biotechnology industry. He was the founder and President and Chief Executive Officer of Alveda Pharmaceuticals Inc. from 2006 until November 2015. Mr. Andrew Strong has been a partner at Pillsbury Winthrop Shaw Pittman since 2015 and leads the Life Sciences Team (Houston, TX). From 2009 to 2011 Mr. Strong served as the General Counsel and Compliance Officer for the Texas A&M University System where he led efforts to secure a multi-billion-dollar federal contract to serve as a first line of defense for influenza pandemics and biological threats. Dr. Chandra Panchal is the Founder of Axcelon Biopolymers Corp. where he is Chairman, CEO and CSO. From 1989 to 1999 he was Co-Founder, President, and CEO of Procyon Biopharma Inc., which he took public on the TSXV in 1998 and later on TSX in 2000.